Medtronic Launches Insulin Pump Infusion Sets With Double Wear Time
Medtronic plc (NYSE: MDT) has launched the Medtronic Extended infusion set in the U.S., the first and only infusion set labeled for up to 7-day wear.
An infusion set is tubing that delivers insulin from an insulin pump to the body and typically requires a set change every two to three days.
The Medtronic Extended infusion set uses advanced materials that help reduce insulin preservative loss and maintain insulin flow and stability to double the wear time of an infusion set.
Also read: Medtronic Shares Fall As Blood Pressure Reduction Device Fails On Primary Goal.
In clinical studies, study participants observed a decrease in the number of times an infusion set needed to be changed by 50%. The number of infusion set failures associated with high glucose levels was lowered.
Additionally, the Medtronic Extended infusion set is estimated to result in annual cost savings of insulin of up to 25% due to a reduced number of the infusion set and reservoir changes that result in unrecoverable insulin as plastic waste reduction of up to 50%.
With the U.S. launch of the Medtronic Extended infusion set, this innovation is now available exclusively for customers using MiniMed 600 and 700 series pumps.
Price Action: MDT shares are up 0.60% at $83.40 on the last check Tuesday.
See more from Benzinga
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
